149 related articles for article (PubMed ID: 30060818)
41. Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties.
Figuera-Losada M; Stathis M; Dorskind JM; Thomas AG; Bandaru VV; Yoo SW; Westwood NJ; Rogers GW; McArthur JC; Haughey NJ; Slusher BS; Rojas C
PLoS One; 2015; 10(5):e0124481. PubMed ID: 26010541
[TBL] [Abstract][Full Text] [Related]
42. Nitric oxide, ceramide and sphingomyelinase-coupled receptors: a tale of enzymes and messengers coordinating cell death, survival and differentiation.
Perrotta C; De Palma C; Falcone S; Sciorati C; Clementi E
Life Sci; 2005 Aug; 77(14):1732-9. PubMed ID: 15946697
[TBL] [Abstract][Full Text] [Related]
43. Stichoposide C induces apoptosis through the generation of ceramide in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
Yun SH; Park ES; Shin SW; Na YW; Han JY; Jeong JS; Shastina VV; Stonik VA; Park JI; Kwak JY
Clin Cancer Res; 2012 Nov; 18(21):5934-48. PubMed ID: 23132899
[TBL] [Abstract][Full Text] [Related]
44. Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.
Pavoine C; Pecker F
Cardiovasc Res; 2009 May; 82(2):175-83. PubMed ID: 19176603
[TBL] [Abstract][Full Text] [Related]
45. Sphingolipid metabolism and neutral sphingomyelinases.
Airola MV; Hannun YA
Handb Exp Pharmacol; 2013; (215):57-76. PubMed ID: 23579449
[TBL] [Abstract][Full Text] [Related]
46. Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact rat brain: Insight into mechanisms and possible relation to brain injury and stroke.
Altura BM; Gebrewold A; Zheng T; Altura BT
Brain Res Bull; 2002 Jul; 58(3):271-8. PubMed ID: 12128152
[TBL] [Abstract][Full Text] [Related]
47. Divergent role of ceramide generated by exogenous sphingomyelinases on NF-kappa B activation and apoptosis in human colon HT-29 cells.
Colell A; Coll O; Mari M; Fernández-Checa JC; García-Ruiz C
FEBS Lett; 2002 Aug; 526(1-3):15-20. PubMed ID: 12208496
[TBL] [Abstract][Full Text] [Related]
48. NADPH Oxidase-Mediated Activation of Neutral Sphingomyelinase Is Responsible for Diesel Particulate Extract-Induced Keratinocyte Apoptosis.
Lee HS; Park HY; Kwon SP; Kim B; Lee Y; Kim S; Shin KO; Park K
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32028642
[TBL] [Abstract][Full Text] [Related]
49. Ceramide accumulation is independent of camptothecin-induced apoptosis in prostate cancer LNCaP cells.
Akao Y; Kusakabe S; Banno Y; Kito M; Nakagawa Y; Tamiya-Koizumi K; Hattori M; Sawada M; Hirabayasi Y; Ohishi N; Nozawa Y
Biochem Biophys Res Commun; 2002 Jun; 294(2):363-70. PubMed ID: 12051721
[TBL] [Abstract][Full Text] [Related]
50. Ceramide in apoptosis--does it really matter?
Hofmann K; Dixit VM
Trends Biochem Sci; 1998 Oct; 23(10):374-7. PubMed ID: 9810222
[TBL] [Abstract][Full Text] [Related]
51. Role of Inositol Phosphosphingolipid Phospholipase C1, the Yeast Homolog of Neutral Sphingomyelinases in DNA Damage Response and Diseases.
Tripathi K
J Lipids; 2015; 2015():161392. PubMed ID: 26346287
[TBL] [Abstract][Full Text] [Related]
52. Involvement of sphingomyelinases in TNF signaling pathways.
Krönke M
Chem Phys Lipids; 1999 Nov; 102(1-2):157-66. PubMed ID: 11001570
[TBL] [Abstract][Full Text] [Related]
53. A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1.
Cinq-Frais C; Coatrieux C; Grazide MH; Hannun YA; Nègre-Salvayre A; Salvayre R; Augé N
Biochim Biophys Acta; 2013 Aug; 1831(8):1344-56. PubMed ID: 23651497
[TBL] [Abstract][Full Text] [Related]
54. p53-Independent ceramide formation in human glioma cells during gamma-radiation-induced apoptosis.
Hara S; Nakashima S; Kiyono T; Sawada M; Yoshimura S; Iwama T; Banno Y; Shinoda J; Sakai N
Cell Death Differ; 2004 Aug; 11(8):853-61. PubMed ID: 15088070
[TBL] [Abstract][Full Text] [Related]
55. Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor.
Adam-Klages S; Schwandner R; Adam D; Kreder D; Bernardo K; Krönke M
J Leukoc Biol; 1998 Jun; 63(6):678-82. PubMed ID: 9620659
[TBL] [Abstract][Full Text] [Related]
56. Sphingomyelinases in cell regulation.
Liu B; Obeid LM; Hannun YA
Semin Cell Dev Biol; 1997 Jun; 8(3):311-322. PubMed ID: 10024495
[TBL] [Abstract][Full Text] [Related]
57. Sphingomyelin hydrolysis during apoptosis.
Andrieu-Abadie N; Levade T
Biochim Biophys Acta; 2002 Dec; 1585(2-3):126-34. PubMed ID: 12531545
[TBL] [Abstract][Full Text] [Related]
58. Neutral sphingomyelinase-2 and cardiometabolic diseases.
Sindhu S; Leung YH; Arefanian H; Madiraju SRM; Al-Mulla F; Ahmad R; Prentki M
Obes Rev; 2021 Aug; 22(8):e13248. PubMed ID: 33738905
[TBL] [Abstract][Full Text] [Related]
59. Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias.
Kim WJ; Okimoto RA; Purton LE; Goodwin M; Haserlat SM; Dayyani F; Sweetser DA; McClatchey AI; Bernard OA; Look AT; Bell DW; Scadden DT; Haber DA
Blood; 2008 May; 111(9):4716-22. PubMed ID: 18299447
[TBL] [Abstract][Full Text] [Related]
60. Exploring the Therapeutic Landscape of Sphingomyelinases.
Shanbhogue P; Hannun YA
Handb Exp Pharmacol; 2020; 259():19-47. PubMed ID: 30478737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
